Prosperity Capital Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$871K Buy
6,782
+145
+2% +$17K 0.04% 204
2026
Q1
$798K Sell
6,637
-673
-9% -$77.7K 0.05% 212
2025
Q4
$769K Buy
7,310
+656
+10% +$61.6K 0.05% 195
2025
Q3
$558K Buy
6,654
+564
+9% +$46.5K 0.03% 264
2025
Q2
$482K Buy
6,090
+181
+3% +$14.4K 0.03% 268
2025
Q1
$515K Sell
5,909
-133
-2% -$12.4K 0.04% 229
2024
Q4
$601K Buy
6,042
+673
+13% +$69.4K 0.05% 204
2024
Q3
$610K Buy
5,369
+261
+5% +$31K 0.05% 203
2024
Q2
$632K Buy
5,108
+20
+0.4% +$2.58K 0.07% 167
2024
Q1
$671K Buy
5,088
+1,353
+36% +$167K 0.08% 180
2023
Q4
$407K Sell
3,735
-648
-15% -$67.3K 0.04% 165
2023
Q3
$451K Buy
4,383
+495
+13% +$53.4K 0.06% 147
2023
Q2
$449K Sell
3,888
-227
-6% -$25.8K 0.06% 145
2023
Q1
$438K Sell
4,115
-121
-3% -$13.1K 0.07% 124
2022
Q4
$470K Buy
+4,236
New +$433K 0.14% 102

Other funds holding MRK

Prosperity Capital Advisors's MRK Position: Q2 2026 in Review

Prosperity Capital Advisors increased its Merck (MRK) stake by 2.2% in Q2 2026, buying an estimated $17K and bringing the position to 6,782 shares worth $871K. The position accounts for 0.04% of the portfolio, ranked #204.

Prosperity Capital Advisors first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Prosperity Capital Advisors held 6,782 shares of Merck worth $871K as of Q2 2026.
  • Prosperity Capital Advisors bought 145 Merck shares in Q2 2026, an estimated $17K.
  • Merck made up 0.04% of Prosperity Capital Advisors's portfolio in Q2 2026, its #204 holding.
  • Prosperity Capital Advisors first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Prosperity Capital Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.